UBS Maintains Buy on Kodiak Sciences, Raises Price Target to $120

UBS analyst Michael Yee has maintained a Buy rating on Kodiak Sciences (NASDAQ: KOD) and raised the price target from $80 to $120. This adjustment reflects positive sentiment regarding the company's performance and potential growth.